KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Shares Outstanding (Weighted Average) (2016 - 2026)

Chemed filings provide 18 years of Shares Outstanding (Weighted Average) readings, the most recent being $13.7 million for Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 6.48% year-over-year to $13.7 million, compared with a TTM value of $13.7 million through Mar 2026, down 6.48%, and an annual FY2025 reading of $14.4 million, down 4.17% over the prior year.
  • Shares Outstanding (Weighted Average) hit $13.7 million in Q1 2026 for Chemed, down from $14.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $15.1 million in Q1 2024, with the low at $13.7 million in Q1 2026.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $15.0 million (2023), compared with a mean of $14.8 million.
  • The sharpest move saw Shares Outstanding (Weighted Average) rose 1.04% in 2024, then dropped 6.48% in 2026.
  • Year by year, Shares Outstanding (Weighted Average) stood at $14.9 million in 2022, then grew by 0.81% to $15.0 million in 2023, then dropped by 0.17% to $15.0 million in 2024, then fell by 4.17% to $14.4 million in 2025, then dropped by 5.02% to $13.7 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $13.7 million, $14.4 million, and $14.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.